Bristol-Myers Squibb (BMY) total liabilities

Total liabilities · fiscal 2025
$71.53B

Bristol-Myers Squibb (BMY) had total liabilities of $71.53B at the end of fiscal 2025 (December 31, 2025). That is 6.1% lower than the $76.22B of fiscal 2024. Figures as of 18 Nov 2026, 19:36 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total liabilities, fiscal 2025
$71.53B
Change on fiscal 2024
−6.1%
Growth, 5 years
−2.4% a year
Growth, 10 years
+15.2% a year
Highest on record
$80.60Bfiscal 2020
Lowest on record
$15.44Bfiscal 2010
Fiscal years on record
182008–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Bristol-Myers Squibb total liabilities, in more detail

Over the five fiscal years to 2025 total liabilities shrank at a compound 2.4% a year; over ten years the rate was 15.2% a year. Across the 18 fiscal years on record (2008–2025), the highest was $80.60B in fiscal 2020 and the lowest $15.44B in fiscal 2010.

History · 18 fiscal years

Total liabilities by fiscal year

Bristol-Myers Squibb total liabilities, year by year

Bristol-Myers Squibb (BMY) total liabilities by fiscal year
Fiscal yearTotal liabilitiesChangeYear ended
2025$71.53B 6.1% down
2024$76.22B 16.1% up
2023$65.67B 0.0% down
2022$65.70B 10.4% down
2021$73.31B 9.0% down
2020$80.60B 3.0% up
2019$78.25B 275.1% up
2018$20.86B 3.9% down
2017$21.70B 25.0% up
2016$17.36B 0.2% up
2015$17.32B 7.7% down
2014$18.77B 19.7% down
2013$23.36B 4.9% up
2012$22.26B 30.1% up
2011$17.10B 10.8% up
2010$15.44B 4.8% down
2009$16.22B 6.1% down
2008$17.28B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest.

How to read it

It is broader than debt: read it against total assets, and remember that for a bank or an insurer customer deposits and policy reserves are liabilities too.

Total liabilities at health care companies of similar size

Total liabilities of Bristol-Myers Squibb and comparable companies
CompanyTotal liabilitiesFiscal year
Vertex Pharmaceuticals VRTX$6.98B2025
Medtronic MDT$42.96B2026
Bristol-Myers Squibb BMY$71.53B2025
Stryker SYK$25.42B2025
McKesson MCK$83.16B2026
Sanofi SNY€55.10B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on BMY

Bristol-Myers Squibb, figure by figure

Bristol-Myers Squibb (BMY) overview: price, valuation and scorecardAll health care companies by market value

Bristol-Myers Squibb total liabilities: questions and answers

How large are Bristol-Myers Squibb's total liabilities?

Bristol-Myers Squibb (BMY) had total liabilities of $71.53B at the end of fiscal 2025 (December 31, 2025). That is 6.1% lower than the $76.22B of fiscal 2024.

What is the growth rate of Bristol-Myers Squibb's total liabilities?

Over the five fiscal years to 2025 total liabilities shrank at a compound 2.4% a year; over ten years the rate was 15.2% a year.

What are the highest and lowest total liabilities figures on record for Bristol-Myers Squibb?

Across the 18 fiscal years on record (2008–2025), the highest was $80.60B in fiscal 2020 and the lowest $15.44B in fiscal 2010.

How is Bristol-Myers Squibb's total liabilities calculated?

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest. For Bristol-Myers Squibb it is on record here for 18 fiscal years, 2008 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Bristol-Myers Squibb (BMY) total liabilities”, data as of 18 November 2026. https://funkfolio.com/stock/BMY/total-liabilities

Underlying data: the company's filings with the SEC and Yahoo Finance.